Walgreens, Teva Accused of Fueling Opioid Addiction in Quest for New Markets

Walgreens, Teva Accused of Fueling Opioid Addiction in Quest for New Markets
People walk by a Walgreens, owned by the Walgreens Boots Alliance Inc., in Manhattan, New York., on Nov. 26, 2021. Andrew Kelly/Reuters
|Updated:

Walgreens Boots Alliance and Teva Pharmaceutical Industries Ltd. ignored the health risks when they created new markets for opioids, a lawyer for the city of San Francisco told a judge on Monday during opening statements of the first trial to target manufacturers, distributors, and pharmacies over the addictive pain medicines.

Richard Heimann, a lawyer for the city, said on Monday that the prescription drug industry was complicit in expanding the market for opioids, regardless of the public health risks.